News
Gilead Sciences Inc. (NASDAQ:GILD) is one of the undervalued S&P 500 stocks to buy according to hedge funds. On June 25, ...
In observance of National HIV Testing Day Friday, several sites across South Florida are offering free rapid HIV testing and ...
In Philadelphia, the leading causes of death are heart disease, cancer, and unintentional drug overdose. While some of these ...
The U.S. Supreme Court preserved the U.S. Preventative Services Task Force coverage mandate that requires payers to cover certain preventive services at no cost to patients in a 6-3 ruling. That’s ...
The Supreme Court upheld free preventive care, rejecting a challenge that threatened coverage for STI testing, cancer ...
Yes, the justices upheld a key part of the Affordable Care Act, but they also said our conspiracy theorist Health Secretary ...
Labcorp (LH), and Gilead (GILD) rise as Supreme Court upholds right to free preventive care under Obamacare. Read more here.
The high court found that members of a task force that determines what preventive drugs must be covered can be removed at ...
(Reuters) -Shares of Gilead rose nearly 3% after the U.S. Supreme Court on Friday preserved a key element of the Obamacare law that helps guarantee that health insurers cover preventive care at no ...
19h
Investor's Business Daily on MSNWhy This Looming Supreme Court Decision Could Rattle Gilead SciencesThe U.S. Supreme Court could make a decision Friday that would rattle Gilead Sciences' newest HIV prevention drug.
Merck announced ACIP voted to recommend Enflosnia (clesrovimab-cfor) as a treatment option for RSV in infants younger than 8 months of age who are born during or entering their first RSV season.
Yeztugo (lenacapavir) will be the first option that gives people who need or want PrEP the option of injecting only twice a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results